Life post-COVID-19: symptoms and chronic complications

Pêgo-Fernandes, Paulo Manuel; Mariani, Alessandro Wasum

doi:10.1590/1516-3180.2021.139104022021

Cited by 8 publications

(9 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This is assuming importance because a surge of discharged patients can place an additional burden on the healthcare system, patients' families, and the society [7]. Oronsky et al [7] from USA and Fernandes et al [8] (from Brazil) provided a review of such symptoms. Walitt and Bartrum [9] provided a clinical primer for the expected and potential post-COVID syndrome.…”

Section: Discussionmentioning

confidence: 99%

Long Term Health Consequences of COVID-19 in Hospitalized Patients from North India: A follow up study of upto 12 months

Budhiraja

Aggarwal

Wig

et al. 2021

Preprint

View full text Add to dashboard Cite

Purpose: Long COVID syndrome is now a real and pressing public health concern. We cannot reliably predict who will recover quickly or suffer with mild debilitating long COVID 19 symptoms or battle life threatening complications. In order to address some of these questions, we studied the presence of symptoms and various correlates in COVID 19 patients who were discharged from hospital, 3 months and up to 12 months after acute COVID 19 illness. Methods: This is an observational follow up study of RT PCR confirmed COVID 19 patients admitted at 3 hospitals in north India between April August 2020. Patients were interviewed telephonically using a questionnaire regarding the post COVID symptoms. The first tele calling was done in the month of September 2020, which corresponded to 4 to 16 weeks after disease onset. All those who reported presence of long COVID symptoms, were followed up with a second call, in the month of March 2021, corresponding to around 9 to 12 months after the onset of disease. Results: Of 990 patients who responded to the first call, 615 (62.2%) had mild illness, 227 (22.9%) had moderate and 148 (15.0%) had severe COVID 19 illness at the time of admission. Nearly 40% (399) of these 990 patients reported at least one symptom at that time. Of these 399 long COVID patients, 311 (almost 78%) responded to the second follow up. Nearly 8% reported ongoing symptomatic COVID, lasting 1 to 3 months and 32% patients having post COVID phase with symptoms lasting 3 to 12 months. Nearly 11% patients continued to have at least one symptom even at the time of the second interview (9 to 12 months after the disease onset). Overall, we observed Long COVID in almost 40% of our study group. Incidence of the symptoms in both the follow ups remained almost same across age groups, gender, severity of illness at admission and presence of comorbidity, with no significant association with any of them. Most common symptoms experienced in long COVID phase in our cohort were fatigue, myalgia, neuro psychiatric symptoms like depression, anxiety, brain fog and sleep disorder, and breathlessness. Fatigue was found to be significantly more often reported in the elderly population and in those patients who had a severe COVID 19 illness at the time of admission. Persistence of breathlessness was also reported significantly more often in those who had severe disease at the onset. The overall median duration of long COVID symptoms was 16.9 weeks with inter quartile range of 12.4 to 35.6 weeks. The duration of symptom resolution was not associated with age, gender or comorbidity but was significantly associated with severity of illness at the time of admission (P=0.006). Conclusions: Long COVID is now being recognized as a new disease entity, which includes a constellation of symptoms. Long COVID was in almost 40% of our study group with no correlation to age, gender, comorbidities or to the disease severity. The duration of symptom resolution was significantly associated with severity of illness at the time of admission (P = 0.006). In our study, all patients reported minor symptoms such as fatigue, myalgia, neuro psychiatric symptoms like depression, anxiety, brain fog and sleep disorder and persistence of breathlessness. Severe organ damage was not reported by our subjects. This might be the longest post COVID follow up study on a sample of nearly 1000 cases from India.

show abstract

Section: Discussionmentioning

confidence: 99%

Long Term Health Consequences of COVID-19 in Hospitalized Patients from North India: A follow up study of upto 12 months

Budhiraja

Aggarwal

Wig

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…There are multiple reports about complications of COVID-19 either in the acute phase of the disease or long-covid (5). Diabetes or hyperglycemia during the course of the disease contribute to more severe forms of the disease, most signi cantly in patients with history of diabetes(6).…”

Section: Introductionmentioning

confidence: 99%

SARS-CoV-2 Infection Related Hyperglycemia during hospitalization and three months post-discharge

Hosseini,

Rashid,

Homayoun

et al. 2024

Preprint

View full text Add to dashboard Cite

Hyperglycemia or diabetes mellitus during COVID-19 has always been a great concern and heralds severe forms of the disease, we also don’t know whether this condition will continue as diabetes mellitus even after convalescence. For this purpose we conducted a study to investigate this condition and factors related to it in hospitalized patients and even three months post-discharge we followed them up. We gathered data from 202 patients that fulfilled our inclusion criteria, among them 100 patients were hyperglycemic. Patients in hyperglycemic status experienced significantly longer duration of hospitalization than normoglycemic patients and significantly showed more severe forms of the disease. During their follow up three months post-discharge for the investigation of glycemic status, 46 out of 97 patients were diagnosed with diabetes mellitus and have been taking anti-diabetic drugs while 29 patients only had normal glycemic status.

show abstract

“…A atual pandemia causada pelo vírus SARS-CoV-2 é um dos maiores desafios dos sistemas de saúde nos dias de hoje, tendo-se disseminado rapidamente por todo o mundo condicionando no futuro um conjunto de sequelas cujo impacto ainda está em avaliação. Em Portugal, o primeiro caso surgiu a 1 de março de 2020, mês em que a Organização Mundial de Saúde (OMS) declarou a COVID-19 uma pandemia global e emergência de saúde pública 1,2 .…”

Section: Introductionunclassified

“…Um ano depois, com o aumento do número de casos recuperados denotou-se que após a alta hospitalar os doentes apresentam défices no autocuidado 10,11 . As sequelas, têm mostrado afetar predominantemente os sistemas respiratório, cardiovascular, renal e neurológico, com sintomas persistentes de dispneia, fadiga, tosse, toracalgia, mialgia, cefaleias, palpitações, anosmia, hiposmia, anorexia e distúrbios cognitivos 2,10,11,12 que caracterizam a síndrome pós-covid. Os sintomas podem persistir durante mais de 3 semanas em 10% dos casos 12 , mas é reportada igualmente a sua persistência até 60 a 110 dias após a alta hospitalar com incidência elevada de fadiga como sintoma mais comum, significativo e duradouro 2,10,12,13 .…”

Section: Introductionunclassified

“…As sequelas, têm mostrado afetar predominantemente os sistemas respiratório, cardiovascular, renal e neurológico, com sintomas persistentes de dispneia, fadiga, tosse, toracalgia, mialgia, cefaleias, palpitações, anosmia, hiposmia, anorexia e distúrbios cognitivos 2,10,11,12 que caracterizam a síndrome pós-covid. Os sintomas podem persistir durante mais de 3 semanas em 10% dos casos 12 , mas é reportada igualmente a sua persistência até 60 a 110 dias após a alta hospitalar com incidência elevada de fadiga como sintoma mais comum, significativo e duradouro 2,10,12,13 . A experiência tem demonstrado que independentemente da gravidade da doença, hospitalização ou sob isolamento domiciliário, a não recuperação total após 2 a 3 semanas da testagem positiva foi relatada por aproximadamente um terço das pessoas 14,15 .…”

Section: Introductionunclassified

See 1 more Smart Citation

Fadiga na pessoa com sequelas da COVID-19, uma proposta de reabilitação: Estudo de Caso

Pestana¹,

Barbosa²,

Mesquita³

et al. 2022

Rev Port Enf Reab

View full text Add to dashboard Cite

Introdução: A COVID-19 pode causar sequelas persistentes, sendo a mais descrita a fadiga. Os enfermeiros especialistas em enfermagem de reabilitação são portadores de conhecimento especializado no controlo e redução da mesma. Objetivo: Pretende-se identificar os ganhos sensíveis à reabilitação respiratória no foco de ventilação e intolerância à atividade; analisar a tolerância ao esforço na pessoa após infeção com-COVID-19 e verificar a efetividade das intervenções do enfermeiro especialista em enfermagem de reabilitação no controlo e redução da fadiga em pessoas com sequelas de COVID-19. Método: Estudo de caso com recolha de dados quantitativos e qualitativos. Apresenta-se o caso de uma pessoa com sequelas pós-COVID e fraqueza muscular adquirida nos cuidados intensivos, caracterizada por uma ventilação ineficaz e intolerância à atividade. Resultados: O processo de enfermagem, integrou as recomendações de reabilitação respiratória da Sociedade Chinesa de Medicina de Reabilitação, com 14 sessões verificou-se: redução de fadiga, aumento da capacidade vital, aumento das distâncias percorridas e aumento da autonomia na realização das AVD. Conclusões: Com a implementação de um plano de cuidados de enfermagem de reabilitação individualizado é possível atuar no controlo e redução da fadiga em pessoas com sequelas da COVID-19, proporcionando ganhos em saúde sensíveis aos cuidados aos cuidados de enfermagem de reabilitação.

show abstract

Life post-COVID-19: symptoms and chronic complications

Cited by 8 publications

References 8 publications

Long Term Health Consequences of COVID-19 in Hospitalized Patients from North India: A follow up study of upto 12 months

Long Term Health Consequences of COVID-19 in Hospitalized Patients from North India: A follow up study of upto 12 months

SARS-CoV-2 Infection Related Hyperglycemia during hospitalization and three months post-discharge

Fadiga na pessoa com sequelas da COVID-19, uma proposta de reabilitação: Estudo de Caso

Contact Info

Product

Resources

About